An outbreak of Monkeypox (MPX) infections and associated disease was recently reported in Europe and North America. As of July 2022, several thousand cases have been confirmed in other countries, including over 3000 in USA. The 2022 global MPX outbreak has been recently declared a Public Health Emergency, is being monitored by health and regulatory agencies worldwide, and has received considerable attention in the general news. We plan to study the immune responses in subjects who have been infected with Monkeypox and have acquired T cell responses to the virus.
As more and more people become infected with this virus, it is important to understand as much as we can about how this virus affects the human immune system. We plan to look at the T and B cell immune response in patients with symptoms and history of Monkeypox disease as well as those that have received a Monkeypox vaccine
Eligibility Criteria (one or more):
- You are a generally healthy male or female, over 18 years of age.
- You have had a positive test for Monkeypox
- Have received/will receive a Monkeypox vaccine